Weight-Loss Effect on FVC in Nintedanib Idiopathic Pulmonary Fibrosis Trials?
作者信息
Assaly Ragheb, Khan Abdur Rahman, Olson Dan E
机构信息
1 University of Toledo Toledo, Ohio.
出版信息
Am J Respir Crit Care Med. 2015 Oct 15;192(8):1020. doi: 10.1164/rccm.201505-0937LE.
PMID:26469846
Abstract
摘要
相似文献
1
Weight-Loss Effect on FVC in Nintedanib Idiopathic Pulmonary Fibrosis Trials?在尼达尼布治疗特发性肺纤维化试验中体重减轻对用力肺活量的影响？
Am J Respir Crit Care Med. 2015 Oct 15;192(8):1020. doi: 10.1164/rccm.201505-0937LE.
2
Reply: Weight-Loss Effect on FVC in Nintedanib Idiopathic Pulmonary Fibrosis Trials?回复：在尼达尼布治疗特发性肺纤维化试验中体重减轻对用力肺活量的影响？
Am J Respir Crit Care Med. 2015 Oct 15;192(8):1020-1. doi: 10.1164/rccm.201507-1354LE.
3
Nintedanib reduced decline in FVC in idiopathic pulmonary fibrosis.尼达尼布可减缓特发性肺纤维化患者的用力肺活量下降。
Ann Intern Med. 2014 Oct 21;161(8):JC5. doi: 10.7326/0003-4819-161-8-201410210-02005.
4
Treatments for idiopathic pulmonary fibrosis.特发性肺纤维化的治疗方法。
N Engl J Med. 2014 Aug 21;371(8):783. doi: 10.1056/NEJMc1407776.
5
Treatments for idiopathic pulmonary fibrosis.特发性肺纤维化的治疗方法。
N Engl J Med. 2014 Aug 21;371(8):781-2. doi: 10.1056/NEJMc1407776.
6
[Idiopathic pulmonary fibrosis. An experimental medication].[特发性肺纤维化。一种实验性药物]
Perspect Infirm. 2015 Jan-Feb;12(1):62.
7
Efficacy and safety of nintedanib in idiopathic pulmonary fibrosis.尼达尼布治疗特发性肺纤维化的疗效和安全性。
N Engl J Med. 2014 May 29;370(22):2071-82. doi: 10.1056/NEJMoa1402584. Epub 2014 May 18.
8
Treatments for idiopathic pulmonary fibrosis.特发性肺纤维化的治疗方法。
N Engl J Med. 2014 Aug 21;371(8):781. doi: 10.1056/NEJMc1407776.
9
A new hope for idiopathic pulmonary fibrosis.特发性肺纤维化的新希望。
N Engl J Med. 2014 May 29;370(22):2142-3. doi: 10.1056/NEJMe1403448. Epub 2014 May 18.
10
Stability or improvement in forced vital capacity with nintedanib in patients with idiopathic pulmonary fibrosis.尼达尼布治疗特发性肺纤维化患者时用力肺活量的稳定性或改善。
Eur Respir J. 2018 Aug 2;52(2). doi: 10.1183/13993003.02593-2017. Print 2018 Aug.
Zotero 插件